ETV4: Research Advances in Malignant Tumors and Tumor Immune Microenvironment—Advances in the Role of ETS Variant Transcription Factor 4 (ETV4) in Tumorigenesis, Tumor Progression and Modulation of Tumor Immune Microenvironment
Advances in Clinical Medicine · 2026 · 16 (04) · 4337-4349
DOI: 10.12677/acm.2026.1641702 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical Medicine, 2026. Verfasst von 瑞鹏 孟. Die Arbeit nennt 65 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
孟, 瑞. (2026). ETV4: Research Advances in Malignant Tumors and Tumor Immune Microenvironment—Advances in the Role of ETS Variant Transcription Factor 4 (ETV4) in Tumorigenesis, Tumor Progression and Modulation of Tumor Immune Microenvironment. Advances in Clinical Medicine, 16(04), 4337-4349. https://doi.org/10.12677/acm.2026.1641702
Vancouver
孟 瑞. ETV4: Research Advances in Malignant Tumors and Tumor Immune Microenvironment—Advances in the Role of ETS Variant Transcription Factor 4 (ETV4) in Tumorigenesis, Tumor Progression and Modulation of Tumor Immune Microenvironment. Advances in Clinical Medicine. 2026;16(04):4337-4349. doi:10.12677/acm.2026.1641702
BibTeX
@article{2026,
author = {孟, 瑞鹏},
title = {ETV4: Research Advances in Malignant Tumors and Tumor Immune Microenvironment—Advances in the Role of ETS Variant Transcription Factor 4 (ETV4) in Tumorigenesis, Tumor Progression and Modulation of Tumor Immune Microenvironment},
journal = {Advances in Clinical Medicine},
year = {2026},
volume = {16},
number = {04},
pages = {4337--4349},
doi = {10.12677/acm.2026.1641702}
}
EUVIMED